Ratings by Guggenheim (Subbu Nambi)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/22/2026 | Danaher | DHR | Maintain | Buy (N/A) |
|
Details | ||
| 7/16/2026 | Tempus AI Inc | TEM | Maintain | Buy (N/A) |
|
Details | ||
| 7/16/2026 | Guardant Health | GH | Maintain | Buy (N/A) |
|
Details | ||
| 7/13/2026 | Bruker | BRKR | Maintain | Buy (Buy) |
|
Details | ||
| 6/29/2026 | GeneDx | WGS | Maintain | Buy (N/A) |
|
Details | ||
| 6/29/2026 | Veracyte, Inc | VCYT | Maintain | Buy (N/A) |
|
Details | ||
| 6/29/2026 | Twist Bioscience | TWST | Maintain | Buy (N/A) |
|
Details | ||
| 6/29/2026 | Natera | NTRA | Maintain | Buy (N/A) |
|
Details | ||
| 6/29/2026 | Illumina | ILMN | Maintain | Buy (N/A) |
|
Details | ||
| 6/29/2026 | Guardant Health | GH | Maintain | Buy (N/A) |
|
Details | ||
| 6/29/2026 | Bruker | BRKR | Maintain | Buy (N/A) |
|
Details | ||
| 6/29/2026 | BillionToOne Inc | BLLN | Maintain | Buy (N/A) |
|
Details | ||
| 6/29/2026 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Buy (N/A) |
|
Details | ||
| 6/1/2026 | Illumina | ILMN | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2026 | BillionToOne Inc | BLLN | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2026 | CryoPort | CYRX | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2026 | Twist Bioscience | TWST | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2026 | GeneDx | WGS | Maintain | Buy (N/A) |
|
Details | ||
| 4/22/2026 | Danaher | DHR | Maintain | Buy (N/A) |
|
Details | ||
| 4/15/2026 | Twist Bioscience | TWST | Maintain | Buy (Buy) |
|
Details | ||
| 3/30/2026 | GeneDx | WGS | Maintain | Buy (N/A) |
|
Details | ||
| 3/30/2026 | Veracyte, Inc | VCYT | Maintain | Buy (N/A) |
|
Details | ||
| 3/30/2026 | Twist Bioscience | TWST | Maintain | Buy (N/A) |
|
Details | ||
| 3/30/2026 | Tempus AI Inc | TEM | Maintain | Buy (N/A) |
|
Details | ||
| 3/30/2026 | Bruker | BRKR | Maintain | Buy (N/A) |
|
Details | ||
| 3/30/2026 | GRAIL, Inc. | GRAL | Maintain | Buy (N/A) |
|
Details | ||
| 3/30/2026 | BillionToOne Inc | BLLN | Maintain | Buy (N/A) |
|
Details | ||
| 3/23/2026 | GRAIL, Inc. | GRAL | Maintain | Buy (Buy) |
|
Details | ||
| 2/27/2026 | Nautilus Biotechnology | NAUT | Maintain | Buy (N/A) |
|
Details | ||
| 1/26/2026 | Twist Bioscience | TWST | Maintain | Buy (N/A) |
|
Details | ||
| 1/26/2026 | Sophia Genetics SA | SOPH | Maintain | Buy (N/A) |
|
Details | ||
| 1/26/2026 | Personalis | PSNL | Maintain | Buy (N/A) |
|
Details | ||
| 1/26/2026 | Illumina | ILMN | Maintain | Buy (N/A) |
|
Details | ||
| 1/26/2026 | GRAIL, Inc. | GRAL | Maintain | Buy (N/A) |
|
Details | ||
| 1/26/2026 | Guardant Health | GH | Maintain | Buy (N/A) |
|
Details | ||
| 1/26/2026 | Castle Biosciences | CSTL | Maintain | Buy (N/A) |
|
Details | ||
| 1/26/2026 | Bruker | BRKR | Maintain | Buy (N/A) |
|
Details | ||
| 1/26/2026 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Buy (N/A) |
|
Details | ||
| 1/9/2026 | Neogen | NEOG | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2026 | Waters Corp. | WAT | New Coverage | Buy (N/A) |
394.97 (383.90) |
-2.8% | Details | |
| 1/6/2026 | BillionToOne Inc | BLLN | New Coverage | Buy (N/A) |
95.00 (133.64) |
40.67% | Details | |
| 1/5/2026 | Veracyte, Inc | VCYT | Maintain | Buy (N/A) |
|
Details | ||
| 1/5/2026 | Natera | NTRA | Maintain | Buy (N/A) |
|
Details | ||
| 1/5/2026 | Illumina | ILMN | Maintain | Buy (N/A) |
|
Details | ||
| 1/5/2026 | Guardant Health | GH | Maintain | Buy (N/A) |
|
Details | ||
| 1/5/2026 | Danaher | DHR | Maintain | Buy (N/A) |
|
Details | ||
| 1/5/2026 | Castle Biosciences | CSTL | Maintain | Buy (N/A) |
|
Details | ||
| 1/5/2026 | Bruker | BRKR | Maintain | Buy (N/A) |
|
Details | ||
| 11/20/2025 | Exact Sciences | EXAS | Downgrade | Neutral (Buy) |
86.18 (104.91) |
21.73% | Details | |
| 11/12/2025 | GRAIL, Inc. | GRAL | Upgrade | Buy (Neutral) |
83.39 (64.42) |
-22.75% | Details | |
| 11/11/2025 | Personalis | PSNL | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2025 | Veracyte, Inc | VCYT | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2025 | Exact Sciences | EXAS | Maintain | Buy (N/A) |
|
Details | ||
| 10/29/2025 | GeneDx | WGS | Maintain | Buy (N/A) |
|
Details | ||
| 10/16/2025 | Illumina | ILMN | Maintain | Buy (Buy) |
|
Details | ||
| 10/16/2025 | Revvity Inc | RVTY | New Coverage | Neutral (N/A) |
91.14 (111.51) |
22.35% | Details | |
| 9/30/2025 | Adeptus Biotechnologies Corp. | ADPT | New Coverage | Buy (N/A) |
13.46 (22.52) |
67.31% | Details | |
| 9/26/2025 | Tempus AI Inc | TEM | Maintain | Buy (N/A) |
|
Details | ||
| 9/25/2025 | Guardant Health | GH | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2025 | Caris Life Sciences Inc | CAI | Maintain | Buy (N/A) |
|
Details | ||
| 7/14/2025 | Caris Life Sciences Inc | CAI | New Coverage | Buy (N/A) |
26.62 (15.59) |
-41.44% | Details | |
| 6/30/2025 | GeneDx | WGS | Maintain | Buy (N/A) |
|
Details | ||
| 6/30/2025 | Tempus AI Inc | TEM | Maintain | Buy (N/A) |
|
Details | ||
| 6/30/2025 | Neogen | NEOG | Maintain | Buy (N/A) |
|
Details | ||
| 5/15/2025 | GeneDx | WGS | New Coverage | Buy (N/A) |
59.45 (61.88) |
4.09% | Details | |
| 5/15/2025 | Neogenomics | NEO | New Coverage | Neutral (N/A) |
7.96 (13.40) |
68.34% | Details | |
| 5/9/2025 | Illumina | ILMN | Maintain | Buy (N/A) |
|
Details | ||
| 4/10/2025 | Neogen | NEOG | Maintain | Buy (N/A) |
|
Details | ||
| 4/9/2025 | Veracyte, Inc | VCYT | Maintain | Buy (N/A) |
|
Details | ||
| 4/9/2025 | Myriad Genetics | MYGN | Downgrade | Neutral (Buy) |
8.07 (5.32) |
-34.08% | Details | |
| 3/28/2025 | Twist Bioscience | TWST | Maintain | Buy (N/A) |
|
Details | ||
| 3/28/2025 | Illumina | ILMN | Maintain | Buy (N/A) |
|
Details | ||
| 3/28/2025 | Exact Sciences | EXAS | Maintain | Buy (N/A) |
|
Details | ||
| 3/28/2025 | Danaher | DHR | Maintain | Buy (N/A) |
|
Details | ||
| 3/28/2025 | CryoPort | CYRX | Maintain | Buy (N/A) |
|
Details | ||
| 3/28/2025 | Castle Biosciences | CSTL | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2025 | Nautilus Biotechnology | NAUT | Maintain | Buy (N/A) |
|
Details | ||
| 2/21/2025 | Guardant Health | GH | Maintain | Buy (N/A) |
|
Details | ||
| 1/17/2025 | Natera | NTRA | Maintain | Buy (N/A) |
|
Details | ||
| 12/19/2024 | Bruker | BRKR | New Coverage | Buy (N/A) |
55.38 (62.91) |
13.6% | Details | |
| 12/19/2024 | Neogen | NEOG | New Coverage | Buy (N/A) |
11.64 (9.19) |
-21.05% | Details | |
| 12/19/2024 | Maravai LifeScience Holdings Inc. | MRVI | New Coverage | Neutral (N/A) |
5.58 (6.86) |
22.94% | Details | |
| 12/19/2024 | Danaher | DHR | New Coverage | Buy (N/A) |
228.30 (199.05) |
-12.81% | Details | |
| 12/19/2024 | CryoPort | CYRX | New Coverage | Buy (N/A) |
7.79 (15.17) |
94.74% | Details | |
| 12/9/2024 | Tempus AI Inc | TEM | New Coverage | Buy (N/A) |
50.44 (42.90) |
-14.95% | Details | |
| 10/17/2024 | GRAIL, Inc. | GRAL | New Coverage | Neutral (N/A) |
14.32 (83.39) |
482.33% | Details | |
| 10/10/2024 | Veracyte, Inc | VCYT | New Coverage | Buy (N/A) |
31.92 (55.65) |
74.34% | Details | |
| 6/28/2024 | Guardant Health | GH | Upgrade | Buy (Neutral) |
29.05 (143.62) |
394.39% | Details | |
| 6/27/2024 | Sophia Genetics SA | SOPH | New Coverage | Buy (N/A) |
4.46 (5.57) |
24.89% | Details | |
| 6/27/2024 | Nautilus Biotechnology | NAUT | New Coverage | Buy (N/A) |
2.22 (1.20) |
-45.95% | Details | |
| 6/25/2024 | 10X Genomics | TXG | Downgrade | Neutral (Buy) |
19.88 (47.05) |
136.67% | Details | |
| 6/18/2024 | Repligen | RGEN | New Coverage | Neutral (N/A) |
124.35 (145.34) |
16.88% | Details | |
| 12/14/2023 | Castle Biosciences | CSTL | New Coverage | Buy (N/A) |
19.99 (23.89) |
19.51% | Details | |
| 12/14/2023 | Myriad Genetics | MYGN | New Coverage | Buy (N/A) |
19.05 (5.32) |
-72.07% | Details | |
| 12/14/2023 | Guardant Health | GH | New Coverage | Neutral (N/A) |
26.79 (143.62) |
436.1% | Details | |
| 12/14/2023 | Natera | NTRA | New Coverage | Buy (N/A) |
58.52 (252.22) |
331% | Details | |
| 12/14/2023 | Exact Sciences | EXAS | New Coverage | Buy (N/A) |
65.52 (86.18) |
31.53% | Details | |
| 12/14/2023 | Akoya Biosciences Inc | AKYA | New Coverage | Neutral (N/A) |
4.26 (1.29) |
-69.72% | Details | |
| 12/14/2023 | Pacific Biosciences of California | PACB | New Coverage | Neutral (N/A) |
8.31 (1.39) |
-83.27% | Details | |
| 12/14/2023 | Illumina | ILMN | New Coverage | Buy (N/A) |
117.64 (192.98) |
64.04% | Details | |
| 12/14/2023 | 10X Genomics | TXG | New Coverage | Buy (N/A) |
48.64 (47.05) |
-3.27% | Details |
